当期报告
$Peak Bio(PKBO)$ 8-K Current report, item 3.01 Accession Number: 0001193125-23-004066 Act: 34 Size: 189 KB 网页链接
10月25日,Ignyte股东批准了合并。合并后公司的股票将于11月2日左右在纳斯达克开始交易,股票代码为PKBO。
PKBO致力于治疗癌症和炎症疾病的治疗方法。该公司的主打产品PHP-303正在等待治疗罕见的孤儿遗传疾病...查看全文
$Peak Bio(PKBO)$ 8-K Current report, item 3.01 Accession Number: 0001193125-23-004066 Act: 34 Size: 189 KB 网页链接
$Peak Bio(PKBO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-23-001674 Act: 33 Size: 10 MB 网页链接
$Peak Bio(PKBO)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001193125-23-001577 Act: 34 Size: 594 KB 网页链接
$Peak Bio(PKBO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-22-305021 Act: 33 Size: 22 MB 网页链接
$Peak Bio(PKBO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-22-290073 Act: 34 Size: 4 MB 网页链接
$Peak Bio(PKBO)$ 8-K/A [Amend] Current report, items 8.01 and 9.01 Accession Number: 0001193125-22-290076 Act: 34 Size: 934 KB 网页链接
$Peak Bio(PKBO)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001193125-22-284608 Act: 34 Size: 24 KB 网页链接
$Peak Bio(PKBO)$ 8-K Current report, items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, and 9.01 Accession Number: 0001193125-22-279204 Act: 34 Size: 2 MB 网页链接
$Peak Bio(PKBO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-22-035202 Size: 6 KB 网页链接
$Peak Bio(PKBO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-035081 Size: 6 KB 网页链接